Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide (Mounjaro) Reimbursement Review CDA-AMC Canada's Drug Agency review of tirzepatide (Mounjaro), covering clinical evidence and price/reimbursement context for Canadian payers
Ozempic (semaglutide) is part of a class of medications known as GLP-1 receptor agonists, which were developed to help manage blood glucose levels in people with diabetes
Over a 48 week treatment period, these combined effects support steady, sustainable weight loss while improving overall metabolic health
N-acetylcysteine (NAC) is a popular supplement known for its ability to increase glutathione production in the body
Keep the lyophilized stuff in these conditions for up to two years to keep it safe
Another meta-analysis showed that HbA1c was reduced 2.1% and body weight 8.6kg with 15mg dose
US$ 22.22
US$ 28.48
US$ 22.76
US$ 29.65
